SIMPLEX TRADING, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$209
+74.2%
5,485
+64.3%
0.00%
Q2 2023$120
-99.9%
3,339
-12.8%
0.00%
Q3 2022$151,0003,831
-65.7%
0.00%
Q1 2021$0
-100.0%
11,159
+1323.3%
0.00%
Q4 2020$33,000
-96.2%
784
-97.6%
0.00%
-100.0%
Q3 2020$870,000
+383.3%
33,127
+230.2%
0.00%
Q1 2020$180,000
+16.1%
10,032
+10.6%
0.00%
Q2 2019$155,000
+1.3%
9,071
-5.1%
0.00%
Q1 2019$153,000
+11.7%
9,562
+1.7%
0.00%
Q4 2018$137,000
-42.4%
9,406
-28.4%
0.00%
-100.0%
Q3 2018$238,000
+83.1%
13,135
+70.2%
0.00%0.0%
Q2 2018$130,000
+5.7%
7,717
+22.0%
0.00%
-80.0%
Q1 2018$123,000
-45.1%
6,325
-42.9%
0.01%
-50.0%
Q4 2017$224,000
+194.7%
11,077
+151.5%
0.01%
+233.3%
Q3 2017$76,000
+300.0%
4,404
+193.6%
0.00%
+200.0%
Q1 2017$19,000
+375.0%
1,500
+385.4%
0.00%
Q3 2015$4,000
-98.7%
309
-97.8%
0.00%
-100.0%
Q2 2015$314,000
+613.6%
13,933
+350.6%
0.03%
+420.0%
Q1 2015$44,0003,0920.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders